nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer
|
Dodwell, David |
|
2005 |
31 |
4 |
p. 274-282 9 p. |
artikel |
2 |
Adjuvant chemotherapy improves survival after resection of stage 1 ovarian cancer
|
Kitchener, Henry C. |
|
2005 |
31 |
4 |
p. 323-327 5 p. |
artikel |
3 |
Approaches to managing bone metastases from breast cancer: The role of bisphosphonates
|
Mystakidou, Kyriaki |
|
2005 |
31 |
4 |
p. 303-311 9 p. |
artikel |
4 |
Brain metastasis of unknown primary: A diagnostic and therapeutic dilemma
|
Polyzoidis, Konstantinos S. |
|
2005 |
31 |
4 |
p. 247-255 9 p. |
artikel |
5 |
Central nervous system metastases in breast cancer patients administered trastuzumab
|
Duchnowska, Renata |
|
2005 |
31 |
4 |
p. 312-318 7 p. |
artikel |
6 |
Editorial board
|
|
|
2005 |
31 |
4 |
p. CO2- 1 p. |
artikel |
7 |
Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia
|
Richards, Sue |
|
2005 |
31 |
4 |
p. 332-335 4 p. |
artikel |
8 |
High-quality evidence in oncology from 25th November to 16th December 2004: a summary
|
Bikerdike, Dr. Liz |
|
2005 |
31 |
4 |
p. 336-338 3 p. |
artikel |
9 |
Neoadjuvant taxanes in the treatment of non-metastatic breast cancer: A systematic review
|
Trudeau, M. |
|
2005 |
31 |
4 |
p. 283-302 20 p. |
artikel |
10 |
Oncology treatment recommendations can be supported only by 1–2% of high-quality published evidence
|
Vincent, Sam |
|
2005 |
31 |
4 |
p. 319-322 4 p. |
artikel |
11 |
Pancreaticoduodenectomy with or without pylorus preservation have similar outcomes
|
Bell Jr., Richard H. |
|
2005 |
31 |
4 |
p. 328-331 4 p. |
artikel |
12 |
Radiotherapeutic management of brain metastases: A systematic review and meta-analysis
|
Tsao, May N. |
|
2005 |
31 |
4 |
p. 256-273 18 p. |
artikel |